BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14247889)

  • 1. SOME MEDICAL ASPECTS OF ORAL CONTRACEPTIVES.
    SWYER GI
    Lancet; 1965 Feb; 1(7380):316-7. PubMed ID: 14247889
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME MEDICAL ASPECTS OF ORAL CONTRACEPTIVES.
    BRAIN ; PARKES AS; BISHOP PM
    Lancet; 1964 Dec; 2(7373):1329-32. PubMed ID: 14224044
    [No Abstract]   [Full Text] [Related]  

  • 3. ORAL CONTRACEPTIVES AND CORONARY THROMBOSIS.
    LLOYD G
    Br Med J; 1965 Feb; 1(5434):587-8. PubMed ID: 14243067
    [No Abstract]   [Full Text] [Related]  

  • 4. ORAL CONTRACEPTION AND CARCINOMA.
    BROWN DB
    Br Med J; 1965 May; 1(5444):1246-7. PubMed ID: 14275030
    [No Abstract]   [Full Text] [Related]  

  • 5. ENDOCRINE PROPERTIES AND LONG-TERM SAFETY OF ORAL CONTRACEPTIVES.
    DRILL VA
    Metabolism; 1965 Mar; 14():SUPPL:295-310. PubMed ID: 14261414
    [No Abstract]   [Full Text] [Related]  

  • 6. THE PILL.
    PARKES AS
    Trans Med Soc Lond; 1964; 80():171-6. PubMed ID: 14270929
    [No Abstract]   [Full Text] [Related]  

  • 7. RELATION OF ARTERIOLES IN THE ENDOMETRIUM TO HEADACHE FROM ORAL CONTRACEPTIVES.
    GRAND EC
    Lancet; 1965 May; 1(7396):1143-4. PubMed ID: 14287319
    [No Abstract]   [Full Text] [Related]  

  • 8. THE DIFFICULTIES AND DANGERS OF ORAL CONTRACEPTION.
    MILLS WG
    Proc R Soc Med; 1964 Mar; 57(3):207-10. PubMed ID: 14130874
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON THE CLINICAL SIGNIFICANCE OF SYNTHETIC PROGESTEROIDS AND THEIR POSSIBLE ROLE IN CARCINOGENESIS].
    TOTH F
    Z Geburtshilfe Gynakol; 1963 Sep; 161():94-102. PubMed ID: 14093621
    [No Abstract]   [Full Text] [Related]  

  • 10. ORAL CONTRACEPTIVES AND BREAST CANCER.
    STOLL BA
    Br Med J; 1964 Oct; 2(5413):875. PubMed ID: 14191891
    [No Abstract]   [Full Text] [Related]  

  • 11. ORAL CONTRACEPTIVES AND BREAST CANCER.
    BRENNAN MJ
    Br Med J; 1965 Feb; 1(5434):587. PubMed ID: 14243066
    [No Abstract]   [Full Text] [Related]  

  • 12. WHAT ARE THE DANGERS OF ORAL CONTRACEPTION?
    SWYER GI
    Proc R Soc Med; 1964 Mar; 57(3):210-2. PubMed ID: 14130875
    [No Abstract]   [Full Text] [Related]  

  • 13. THE ORAL PROGESTATIONAL AND ANTI-OVULATORY PROPERTIES OF MEGESTROL ACETATE AND ITS THERAPEUTIC USE IN GYNAECOLOGICAL DISORDERS.
    OSTERGAARD E
    J Obstet Gynaecol Br Commonw; 1965 Feb; 72():45-58. PubMed ID: 14257019
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL EFFECTIVENESS OF A LOW-DOSE PROGESTIN-ESTROGEN COMBINATION.
    ROVINSKY JJ
    Obstet Gynecol; 1964 Jun; 23():840-50. PubMed ID: 14168244
    [No Abstract]   [Full Text] [Related]  

  • 15. [MEDICAL INDICATION FOR THE INHIBITION OF OVULATION].
    PEETERS F; VANROY M; OEYEN R; SNAUWAERT R; VANTILBORG A
    Internist (Berl); 1964 Jun; 5():246-51. PubMed ID: 14234762
    [No Abstract]   [Full Text] [Related]  

  • 16. [BLOCK OF OVULATION AND BLOCK OF NIDATION].
    CIULLA U
    Riv Ostet Ginecol Prat; 1964 May; 46():393-400. PubMed ID: 14171510
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ORAL CONTRACEPTIVES AND LIVER DAMAGE.
    STOLL BA; ANDREWS JT; MOTTERAM R; UPFILL J
    Br Med J; 1965 Mar; 1(5436):723. PubMed ID: 14245215
    [No Abstract]   [Full Text] [Related]  

  • 19. [HORMONAL INHIBITION OF OVULATION. II].
    LEQUIN RM
    Pharm Weekbl; 1964 Feb; 99():209-23. PubMed ID: 14139143
    [No Abstract]   [Full Text] [Related]  

  • 20. ORAL CONTRACEPTIVES AND BREAST CANCER.
    SHIPMAN JJ
    Br Med J; 1964 Sep; 2(5409):629. PubMed ID: 14171078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.